D-3-1 睡眠時無呼吸症候群に対する分2製剤の防風通聖散料エキス細粒の有用性(治療支援(1))

抄録

Bofu-tsusho-san - a Kampo preparation indicated for the treatment of obesity - was administered to obese SAS patients for a duration of eight weeks, and its usefulness was tested. To all patients, Continuous Positive Airway Pressure (CPAP) therapy, the standard treatment for SAS was provided. For this reason, the Apnea Hypopnea Index (AHI) was kept to a mild level or below, and changes were not observed in the approximate administration of Bofu-tsusho-san. Significant changes in Body Mass Index (BMI), neck girth and abdominal girth, were not observed, either. However, ESS scores were observed decreasing over time, with a significant difference after eight weeks of administration..